🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Palvella Therapeutics, Inc. (PVLA)
NASDAQ: PVLA · Real-Time Price · USD
146.94
+1.17 (0.80%)
Nov 20, 2026, 11:55 AM EST - Market open

Palvella Therapeutics Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$246
BuyReiterates$246+67.42%Nov 20, 2026
BTIG
BTIG
Buy
Maintains
$215
BuyMaintains$215+46.32%Nov 20, 2026
Oppenheimer
Oppenheimer
Buy
Reiterates
$232
BuyReiterates$232+57.89%Nov 20, 2026
Unknown Analyst
Leerink Partners
No rating
Leerink Partners
Buy
Initiates
$228
BuyInitiates$228+55.17%Nov 16, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$232 → $243
BuyReiterates$232 → $243+65.37%Nov 9, 2026
Raymond James
Raymond James
Buy
Maintains
$226 → $230
BuyMaintains$226 → $230+56.53%Nov 6, 2026
Truist Financial
Truist Financial
Buy
Maintains
$207
BuyMaintains$207+40.87%Nov 6, 2026
Craig-Hallum
Craig-Hallum
Buy
Maintains
$205 → $230
BuyMaintains$205 → $230+56.53%Nov 6, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.